000 01133 a2200349 4500
005 20250515114342.0
264 0 _c20080501
008 200805s 0 0 eng d
022 _a1549-4713
024 7 _a10.1016/j.ophtha.2007.10.029
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMignogna, Michele D
245 0 0 _aIntravenous immunoglobulins and mucous membrane pemphigoid.
_h[electronic resource]
260 _bOphthalmology
_cApr 2008
300 _a752-752.e1 p.
_bdigital
500 _aPublication Type: Letter
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aImmunoglobulins, Intravenous
_xadverse effects
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aPemphigoid, Benign Mucous Membrane
_xdrug therapy
650 0 4 _aPilot Projects
650 0 4 _aTreatment Outcome
700 1 _aLeuci, Stefania
700 1 _aPiscopo, Raffaele
700 1 _aBonovolontà, Giulio
773 0 _tOphthalmology
_gvol. 115
_gno. 4
_gp. 752-752.e1
856 4 0 _uhttps://doi.org/10.1016/j.ophtha.2007.10.029
_zAvailable from publisher's website
999 _c17886675
_d17886675